Analysts expect Mineralys Therapeutics, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.27 M | 14.74 M | 15.78 M | 14.33 M | 51.89 M | 68.22 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.97 M | 13.61 M | 14.71 M | 13.40 M | 46.40 M | 63.81 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.12 M | 14.17 M | 15.24 M | 13.87 M | 49.14 M | 66.02 M |
Analysts expect Mineralys Therapeutics, Inc. to report earnings per share of -0.53 for Q3 26, against a range of -0.55 to -0.51. The most recent reported quarter, Q2 26, came in at -2.85, a 391.4% miss against the -0.58 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.13 | -0.98 | -0.79 | -0.66 | -0.52 | -0.40 | -0.47 | -2.85 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.75 | -1.03 | -0.99 | -0.69 | -0.52 | -0.51 | -0.43 | -0.56 | -0.51 | -0.55 | -0.70 | -0.49 | 0.22 | -0.02 | -0.58 | -0.83 | ||||||||||
| Low Estimate | -0.85 | -1.21 | -1.07 | -0.75 | -0.64 | -0.57 | -0.47 | -0.60 | -0.55 | -0.61 | -0.74 | -0.59 | 0.20 | -0.02 | -0.62 | -0.93 | ||||||||||
| Consensus Estimate | -0.80 | -1.12 | -1.03 | -0.72 | -0.58 | -0.54 | -0.45 | -0.58 | -0.53 | -0.58 | -0.72 | -0.54 | 0.21 | -0.02 | -0.60 | -0.88 |
Pull Wall Street consensus for Mineralys Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=MLYS&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "MLYS", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=MLYS&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();